Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel compounds synthesized at SmithKline Beecham act at several 5-HT receptor subtypes

Jan. 4, 1999

New treatment for AIDS-related pain progresses to clinical testing

Jan. 4, 1999

Novo Nordisk describes novel muscarinic cholinergic receptor modulators

Dec. 30, 1998

First U.S. marketing approval for Cephalon: Provigil cleared for narcolepsy-associated EDS

Dec. 29, 1998

YM-872: neuroprotective effects in animal model indicate potential in acute ischemic stroke

Dec. 29, 1998

Peripheral nerve regeneration enhanced by hyaluronic acid in rat model

Dec. 29, 1998

More CRF antagonists emerge from Janssen/Neurocrine Biosciences collaboration

Dec. 29, 1998

Guilford patents NAALADase inhibitors for glutamate abnormalities, prostate conditions

Dec. 28, 1998

Revolutionary drugs for Alzheimer's ready for human testing described by Nymox

Dec. 28, 1998

Agents for epilepsy, stroke and brain, spinal cord trauma in development at Novartis

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...